EMDR for panic disorder with agoraphobia: Comparison with waiting list and credible attention-placebo control conditions.

Goldstein, Alan J., de Beurs, Edwin, Chambless, Dianne L., Wilson, Kimberly A.·2000·Journal of Consulting and Clinical Psychology

Abstract

In a randomized controlled trial, eye movement desensitization and reprocessing (EMDR) for panic disorder with agoraphobia (PDA) was compared with both waiting list and credible attention-placebo control groups. EMDR was significantly better than waiting list for some outcome measures (questionnaire, diary, and interview measures of severity of anxiety, panic disorder, and agoraphobia) but not for others (panic attack frequency and anxious cognitions). However, low power and, for panic frequency, floor effects may account for these negative results. Differences between EMDR and the attention-placebo control condition were not statistically significant on any measure, and, in this case, the effect sizes were generally small (eta2 = .00-.06), suggesting the poor results for EMDR were not due to lack of power. Because there are established effective treatments such as cognitive-behavior therapy for PDA, these data, unless contradicted by future research, indicate EMDR should not be the first-line treatment for this disorder.

Cites (14)

  1. Assessment of social adjustment by patient self report.
    Weissman, Myrna M. · 1976 · Archives of General Psychiatry
  2. Credibility of analogue therapy rationales
    Borkovec, Thomas D., Nau, Sidney D. · 1972 · Journal of Behavior Therapy and Experimental Psychiatry
  3. Update on empirically validated therapies, II: (619622010-001)
    Chambless, Dianne L., Baker, Mary J., Baucom, Donald H., Beutler, Larry E., Calhoun, Karen S., Crits-Christoph, Paul, Daiuto, Anthony, DeRubeis, Robert, Detweiler, Jerusha, Haaga, David A. F. et al. · 1997 · PsycEXTRA Dataset
  4. Assessment of fear of fear in agoraphobics: The Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire
    Chambless, Dianne L., Caputo, G. Craig, Bright, Priscilla, Gallagher, Richard · 1984 · Journal of Consulting and Clinical Psychology
  5. Multicenter Collaborative Panic Disorder Severity Scale
    Shear, M. Katherine, Brown, Timothy A., Barlow, David H., Money, Roy, Sholomskas, Diane E., Woods, Scott W., Gorman, Jack M., Papp, Laszlo A. · 1997 · American Journal of Psychiatry
  6. The Mobility Inventory for Agoraphobia
    Chambless, Dianne L., Caputo, G.Craig, Jasin, Susan E., Gracely, Edward J., Williams, Christine · 1985 · Behaviour Research and Therapy
  7. Empirically supported individual and group psychological treatments for adult mental disorders
    DeRubeis, Robert J., Crits-Christoph, Paul · 1998 · Journal of Consulting and Clinical Psychology
  8. Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia: A Controlled Study in London and Toronto
    Marks, Isaac M., Swinson, Richard P., Başoǧlu, Metin, Kuch, Klaus, Noshirvani, Homa, O'Sullivan, Geraldine, Lelliott, Paul T., Kirby, Marlene, McNamee, Gary, Sengun, Seda et al. · 1993 · British Journal of Psychiatry
  9. Brief cognitive therapy for panic disorder: A randomized controlled trial.
    Clark, David M., Salkovskis, Paul M., Hackmann, Ann, Wells, Adrian, Ludgate, John, Gelder, Michael · 1999 · Journal of Consulting and Clinical Psychology
  10. Normative values for the Beck Anxiety Inventory, Fear Questionnaire, Penn State Worry Questionnaire, and Social Phobia and Anxiety Inventory
    Gillis, Martha M., Haaga, David A. F., Ford, Gary T. · 1995 · Psychological Assessment

Show all 14 references

Cited by (16)

  1. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
    Katzman, Martin A, Bleau, Pierre, Blier, Pierre, Chokka, Pratap, Kjernisted, Kevin, Van Ameringen, Michael, the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University · 2014 · BMC Psychiatry
  2. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision
    Bandelow, Borwin, Zohar, Joseph, Hollander, Eric, Kasper, Siegfried, Möller, Hans-Jürgen, WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, Borwin, Zohar, Joseph, Hollander, Eric, Kasper, Siegfried et al. · 2008 · The World Journal of Biological Psychiatry
  3. Placebo interventions for all clinical conditions
    Hróbjartsson, Asbjørn, Gøtzsche, Peter C · 2010 · Cochrane Database of Systematic Reviews
  4. Establishing Specificity in Psychotherapy: A Meta-Analysis of Structural Equivalence of Placebo Controls.
    Baskin, Thomas W., Tierney, Sandy Callen, Minami, Takuya, Wampold, Bruce E. · 2003 · Journal of Consulting and Clinical Psychology
  5. Psychology should list empirically supported principles of change (ESPs) and not credential trademarked therapies or other treatment packages
    Rosen, Gerald M., Davison, Gerald C. · 2003 · Behavior Modification

See all 87

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: EMDR for panic disorder with agoraphobia: Comparison with waiting list and credible attention-placebo control conditions. https://app.cochat.ai/papers/10.1037//0022-006x.68.6.947
The paper
Goldstein, A. J., de Beurs, E., Chambless, D. L., & Wilson, K. A. (2000). EMDR for panic disorder with agoraphobia: Comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037//0022-006x.68.6.947

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.